These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 1560840)

  • 21. Defective vaccine-induced resistance to Schistosoma mansoni in P strain mice. III. Specificity of the associated defect in cell-mediated immunity.
    James SL; Deblois LA; Al-Zamel F; Glaven J; Langhorne J
    J Immunol; 1986 Dec; 137(12):3959-67. PubMed ID: 3097138
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunoregulatory idiotypes stimulate T helper 1 cytokine responses in experimental Schistosoma mansoni infections.
    Montesano MA; Freeman GL; Secor WE; Colley DG
    J Immunol; 1997 Apr; 158(8):3800-4. PubMed ID: 9103446
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lack of antigen-specific Th1 response alters granuloma formation and composition in Schistosoma mansoni-infected MyD88-/- mice.
    Layland LE; Wagner H; da Costa CU
    Eur J Immunol; 2005 Nov; 35(11):3248-57. PubMed ID: 16276483
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The immune response to Schistosoma mansoni infections in inbred rats. VI. Regulation by T cell subpopulations.
    Phillips SM; Walker D; Abdel-Hafez SK; Linette GP; Doughty BL; Perrin PJ; el Fathelbab N
    J Immunol; 1987 Oct; 139(8):2781-7. PubMed ID: 2888824
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The responses to Schistosoma mansoni of infected mice and non-infected mice following parabiosis. I--Histological aspects.
    Fuks MA; Santa Rosa GL; Savino W; Goulart EG
    An Microbiol (Rio J); 1982; 27():129-38. PubMed ID: 6765355
    [No Abstract]   [Full Text] [Related]  

  • 26. Studies with double cytokine-deficient mice reveal that highly polarized Th1- and Th2-type cytokine and antibody responses contribute equally to vaccine-induced immunity to Schistosoma mansoni.
    Hoffmann KF; James SL; Cheever AW; Wynn TA
    J Immunol; 1999 Jul; 163(2):927-38. PubMed ID: 10395689
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunopathogenesis of schistosomiasis.
    Wynn TA; Thompson RW; Cheever AW; Mentink-Kane MM
    Immunol Rev; 2004 Oct; 201():156-67. PubMed ID: 15361239
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Recognition of different Schistosoma mansoni antigens by specific human T cell clones.
    Contigli C; Doughty BL; Cone JC; Goes AM
    Cell Immunol; 1994 Mar; 154(1):77-87. PubMed ID: 8118891
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Elevated type 1, diminished type 2 cytokines and impaired antibody response are associated with hepatotoxicity and mortalities during Schistosoma mansoni infection of CD4-depleted mice.
    Fallon PG; Richardson EJ; Smith P; Dunne DW
    Eur J Immunol; 2000 Feb; 30(2):470-80. PubMed ID: 10671202
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Production of the lymphokine soluble immune response suppressor (SIRS) during chronic experimental schistosomiasis mansoni.
    Aune TM; Freeman GL; Colley DG
    J Immunol; 1985 Oct; 135(4):2768-71. PubMed ID: 4031499
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In vivo effects of monoclonal anti-L3T4 antibody on immune responsiveness of mice infected with Schistosoma mansoni. Reduction of irradiated cercariae-induced resistance.
    Kelly EA; Colley DG
    J Immunol; 1988 Apr; 140(8):2737-45. PubMed ID: 3128606
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dermal endothelial cells and keratinocytes produce IL-7 in vivo after human Schistosoma mansoni percutaneous infection.
    Roye O; Delhem N; Trottein F; Remoué F; Nutten S; Decavel JP; Delacre M; Martinot V; Cesbron JY; Auriault C; Wolowczuk I
    J Immunol; 1998 Oct; 161(8):4161-8. PubMed ID: 9780189
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Schistosoma mansoni: genetic restriction and cytokine profile of the CD4 + T helper cell response to dominant epitope peptide of major egg antigen Sm-p40.
    Hernandez HJ; Edson CM; Harn DA; Ianelli CJ; Stadecker MJ
    Exp Parasitol; 1998 Sep; 90(1):122-30. PubMed ID: 9709038
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Induction of platelet cytotoxic functions by lymphokines: role of interferon-gamma.
    Pancre V; Joseph M; Mazingue C; Wietzerbin J; Capron A; Auriault C
    J Immunol; 1987 Jun; 138(12):4490-5. PubMed ID: 3108393
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Characterization of Schistosoma mansoni antigen-reactive T cell clones that form granulomas in vitro.
    Lammie PJ; Linette GP; Phillips SM
    J Immunol; 1985 Jun; 134(6):4170-5. PubMed ID: 3886799
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The regulation of resistance to Schistosoma mansoni by a soluble alpha/beta TCR analog, produced by a cloned T cell hybridoma.
    Perrin PJ; Phillips SM
    Cell Immunol; 1993 Jun; 149(1):155-69. PubMed ID: 8513510
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunodepression in mice following Schistosoma mansoni infection.
    Mota-Santos TA; Gazzinelli G; Ramalho-Pinto FJ; Pellegrino J; da Silva WD
    Rev Inst Med Trop Sao Paulo; 1976; 18(4):246-50. PubMed ID: 1085981
    [No Abstract]   [Full Text] [Related]  

  • 38. Markers and subpopulations of T lymphocytes in schistosomiasis.
    Khalil HM; Makled MK; el Missiry AG; Makarem SS; Maddison S; Sedky HA; Fikry AA
    J Egypt Soc Parasitol; 1987 Jun; 17(1):325-39. PubMed ID: 3106518
    [No Abstract]   [Full Text] [Related]  

  • 39. Schistosomiasis mansoni: a granulomatous disease of cell-mediated immune etiology.
    Boros DL
    Ann N Y Acad Sci; 1976; 278():36-46. PubMed ID: 786125
    [No Abstract]   [Full Text] [Related]  

  • 40. Studies on schistosomiasis. 18. Some factors affecting resistance to Schistosoma mansoni infections in albino mice.
    HUNTER GW; CRANDALL RB; ZICKAFOOSE DE; PURVIS QB
    Am J Trop Med Hyg; 1962 Jan; 11():17-24. PubMed ID: 14450050
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.